Chiusura precedente | 0,1000 |
Aperto | N/D |
Denaro | 0,0000 |
Domanda | 0,2500 |
Prezzo d'esercizio | 17,50 |
Scadenza | 2024-06-21 |
Min-Max giorno | 0,1000 - 0,1000 |
Contratto - Min-Max | N/D |
Volume | |
Open Interest | 1 |
LYON, France, September 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the upcoming Morgan Stanley 21st Annual Global Healthcare Conference and the H.C. Wainwright 25th Annual Global Investment Conference, both being held September 11-13, 2023, in New York City. H.C. Wainwright presentation details: Date:T
- Record second quarter and first half revenues of EUR 14.3 million (USD 15.5 million) and EUR 29.1 million (USD 31.5 million), respectively - - Total HIFU Q2 2023 year-over-year revenue growth of 63.6% - - Strong Q2 2023 year-over-year U.S. Focal One® HIFU procedure growth of 85% - - Received reimbursement approval in Switzerland for use of HIFU in the treatment of prostate cancer - - More than half of patients now enrolled in Phase 3 study evaluating Focal One HIFU in endometriosis - - Appoint
- Company to host conference call and webcast on Thursday, August 24th at 8:30 am EDT - LYON, France, August 10, 2023 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the second quarter ended June 30th, 2023, before the markets open on Thursday, August 24th, 2023. An accompanying conference call and webcast will be hosted by Ryan Rhodes, Chief Executive Officer, François Dietsch, Chief Financial Offi